'Pulmonary vascular' presentation slideshows

PULMONARY HYPERTENSION ETIOPATHOGENESIS & CLASSIFICATION PART- I

PULMONARY HYPERTENSION ETIOPATHOGENESIS & CLASSIFICATION PART- I. Presented by : Dr RAKESH JAIN Senior Resident, Dept of cardiology Medical College, CALICUT July 15 TH , 2013. DEFINITION OF PAH. Current hemodynamic definition is a mPAP >25 mm Hg and

1.07k views • 77 slides

Only 2 more units left in Nurs 2202 - Hang in there We all get tired!!

Only 2 more units left in Nurs 2202 - Hang in there We all get tired!!. Remember in term neonate Extracellular water content is 70-75%. In reterm neonates maybe 90%. Factors associated with prematurity. Neonatal resuscitation supplies And equipment. Narcan.

788 views • 67 slides

Complications of Acute M.I.

590 views • 50 slides

HAEMODYNAMICS OF MITRAL STENOSIS

HAEMODYNAMICS OF MITRAL STENOSIS. DR VINOD G V. Normal MVA 4-5 cm2 No pressure gradient across mitral valve during diastole Consequence of narrowed orifice 1.Development of pressure gradient across mitral valve 2.Progressive rise in LA pressure, pulmonary venous pressure

986 views • 39 slides

HAEMODYNAMICS OF MITRAL STENOSIS

HAEMODYNAMICS OF MITRAL STENOSIS. DR VINOD G V. Normal MVA 4-5 cm2 No pressure gradient across mitral valve during diastole Consequence of narrowed orifice 1.Development of pressure gradient across mitral valve 2.Progressive rise in LA pressure, pulmonary venous pressure

664 views • 39 slides

Pulmonary Hypertension

Pulmonary Hypertension. Kruti Jambula 4.15.11. Definition. PH when a disease elevates pulmonary arterial pressure above normal. Pulmonary arterial pressure = LA pressure+ (Pulmonary blood flow x Pulmonary Vascular Resistance) PA pressure >25mm Hg is abnormal.

623 views • 33 slides

Pulmonary Hypertension

Pulmonary Hypertension. Kruti Jambula 4.15.11. Definition. PH when a disease elevates pulmonary arterial pressure above normal. Pulmonary arterial pressure = LA pressure+ (Pulmonary blood flow x Pulmonary Vascular Resistance) PA pressure >25mm Hg is abnormal.

522 views • 33 slides

CONGENITAL HEART DISEASE.

CONGENITAL HEART DISEASE. Anatomy of the Heart. Figure 12.2. Epidemiology. Prevalence:0.5-0.8% of live births (8/1000).Leading cause ofdeath in children with CHD. Etiology:Unknown,multifactorial inheritance,genetic factors implicated,high incidence in first degree relatives.

798 views • 27 slides

??? ???? ?????? ??????

337 views • 24 slides

Pathology of Pulmonary Hypertension

Pathology of Pulmonary Hypertension. Wolter J. Mooi Department of Pathology, VUmc Amsterdam WJ.Mooi@VUmc.nl. Pulmonary arterial hypertension (WHO definition). Sustained elevation of pulmonary arterial pressure to more than 25 mm Hg at rest, or to more than 30 mm Hg with exercise

1.91k views • 14 slides

CONGENITAL HEART DISEASE.

CONGENITAL HEART DISEASE. SADATH ALI KHAN. Epidemiology. Prevalence:0.5-0.8% of live births (8/1000).Leading cause ofdeath in children with CHD. Etiology:Unknown,multifactorial inheritance,genetic factors implicated,high incidence in first degree relatives.

279 views • 9 slides

MHC Peptide Tetramer

Creative Peptides has launched a series of MHC-peptide Tetramers which are ready-to-use reagents conjugated to a fluorochrome group such as Brilliant Violet 421(BV421), phycoerythrin (PE), or allophycocyanin (APC).https://www.creative-peptides.com/product/mhc-peptide-tetramer-52.html

38 views • 2 slides

Bivalirudin Trifluoroacetate

https://www.creative-peptides.com/product/bivalirudin-trifluoroacetate-item-10-101-06-16.html

23 views • 2 slides

Pulmonary Arterial Hypertension (PAH)

PAH Study-Healthy Solutions is offering a professional & expert team of doctors which serve the world-class cure and therapeutics of Pulmonary Arterial Hypertension (PAH) to the patient.

21 views • 1 slides